Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
112 SEK | +3.23% |
|
+1.36% | +42.49% |
Business Summary
Number of employees: 124
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Hereditary Diseases
65.0
%
| - | - | 110 | 65.0 % | - |
Oncology
20.0
%
| - | - | 34 | 20.0 % | - |
Transplantation
15.0
%
| - | - | 25 | 15.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe (excluding Sweden), Middle East and Africa
82.3
%
| 109 | 85.7 % | 139 | 82.3 % | +28.42% |
North and South America
8.2
%
| 3 | 2.5 % | 14 | 8.2 % | +333.96% |
Sweden
5.9
%
| 11 | 8.4 % | 10 | 5.9 % | -6.06% |
Asia
3.6
%
| 4 | 3.4 % | 6 | 3.6 % | +43.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulf Axel Klangby
FOU | Founder | 55 | 31/12/03 |
Fredrik Alpsten
CEO | Chief Executive Officer | 58 | - |
Sabina Berlin
DFI | Director of Finance/CFO | 41 | 31/12/20 |
Göran Rydin
COO | Chief Operating Officer | 55 | 31/12/20 |
Camilla Wiberg
HRO | Human Resources Officer | - | 31/08/22 |
Theis Kipling
PRN | Corporate Officer/Principal | - | 31/05/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 31/12/20 | |
Director/Board Member | 52 | 31/12/21 | |
Chairman | 55 | 31/12/09 | |
Lars Höckenström
BRD | Director/Board Member | 68 | 31/12/15 |
Ulf Axel Klangby
FOU | Founder | 55 | 31/12/03 |
Fredrik Dahl
BRD | Director/Board Member | - | 31/12/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,284,469 | 8,379,504 ( 51.46 %) | 0 | 51.46 % |
Company contact information
![address Devyser Diagnostics AB(DVYSR)](https://cdn.zonebourse.com/static/address/130269481.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.49% | 174M | |
+37.76% | 52.5B | |
-7.47% | 39.01B | |
+37.72% | 39.31B | |
+11.93% | 26.2B | |
-11.17% | 26.57B | |
+16.45% | 28.2B | |
+45.05% | 14.15B | |
+33.13% | 12.62B | |
-3.46% | 11.74B |
- Stock Market
- Equities
- DVYSR Stock
- Company Devyser Diagnostics AB